THIS SITE IS INTENDED FOR US AUDIENCES ONLY

Otezla for Plaque Psoriasis

Oral psoriasis therapy has a different look*

Start Your Patients Today

*Otezla significantly increased PASI-75 response (n = 562) at week 16 (primary endpoint) vs placebo (n = 282) (33% vs 5%; P < 0.0001)

Take a look at our growing numbers in plaque psoriasis and psoriatic arthritis

16,100+

prescribers of Otezla
since approval

108,500+

patients prescribed Otezla
since approval

Includes all prescribers and prescriptions from April 2014 through September 2016.

click here to learn more about the Otezla® (apremilast) ProPlus program

Our program for healthcare professionals

Learn more

Prescribing Otezla

Learn how to get patients started on Otezla

Learn more

Otezla Specialty Pharmacy Resource

Download a list of specialty pharmacies that offer support services for prescribing Otezla.

Download PDF

Request
a Rep

Learn more from an Otezla Sales Representative

Submit a Request
*

Otezla significantly increased PASI-75 response (n = 562) at week 16 (primary endpoint) vs placebo (n = 282) (33% vs 5%; P < 0.0001)

Includes all prescribers and prescriptions from April 2014 through September 2016.

Indications & Important Safety Information

Please click here for Full Prescribing Information.

You are leaving the Otezla® (apremilast) website

Do you wish to leave this site?

Are You a
Healthcare Professional?

For patients who
have commercial insurance,

Getting Otezla

Just Got
Easier

Now there are no biologic
agent step-edit requirements

on certain prescription benefit plans.

Call your otezla sales representative
today to learn which plans